)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Aquestive Therapeutics
Aquestive Therapeutics (AQST) investor relations material
Aquestive Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary10 Jun, 2026
Opening remarks and agenda
Meeting called to order with agenda and rules of conduct available on the virtual site.
Attendees included board members, senior leadership, independent auditors, and election inspectors.
Stockholders could submit questions throughout the meeting and during a dedicated Q&A session.
Board and executive committee updates
Board members and senior leadership, including CEO, CFO, and other key officers, were introduced.
Representatives from KPMG and Broadridge Financial Solutions were present.
Strategic initiatives and plans
Focus on FDA acceptance of NDA for Anaphylm, aiming for resubmission in Q3 2026.
Commercial launch preparations for Anaphylm targeted for early 2027, with a 75-person sales force.
Global regulatory progress in the U.K., Europe, and Canada, with no further clinical work required for submissions.
Pipeline development includes AQST-108, with promising phase I safety results in androgenic alopecia.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Aquestive Therapeutics
- Q1 2026 revenue rose 66% to $14.4M, net loss narrowed, and key regulatory milestones advanced.AQST
Q1 202614 May 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.AQSTProxy filing24 Apr 2026
- Stockholders will vote virtually on directors, executive pay, and auditor, focusing on governance and sustainability.AQSTProxy filing24 Apr 2026
- Anaphylm's NDA resubmission is on track for Q3, with launch prep backed by strong cash reserves.AQSTThe Citizens Life Sciences Conference 202610 Mar 2026
- Anaphylm targets Q3 2024 resubmission, with strong financials and market readiness.AQSTLeerink Global Healthcare Conference 20269 Mar 2026
- Anaphylm NDA resubmission set for Q3 2026; 2025 net loss $83.8M; 2026 revenue up to $50M.AQSTQ4 20255 Mar 2026
- Anaphylm sublingual film targets FDA approval in Q1 2027, aiming to disrupt the allergy market.AQSTOppenheimer 36th Annual Healthcare Life Sciences Conference26 Feb 2026
- Anaphylm sublingual film targets rapid, needle-free anaphylaxis relief with U.S. launch in 2025.AQSTH.C. Wainwright 27th Annual Global Investment Conference3 Feb 2026
- FDA requires new human factors and PK studies; resubmission targeted for Q3 2026.AQSTStatus update2 Feb 2026
Next Aquestive Therapeutics earnings date
Q2 202611 Aug, 2026
Aquestive Therapeutics
Next Aquestive Therapeutics earnings date
Q2 202611 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage